Literature DB >> 34954332

Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration.

Robert S Molday1, Fabian A Garces2, Jessica Fernandes Scortecci2, Laurie L Molday2.   

Abstract

ABCA4 is a member of the superfamily of ATP-binding cassette (ABC) transporters that is preferentially localized along the rim region of rod and cone photoreceptor outer segment disc membranes. It uses the energy from ATP binding and hydrolysis to transport N-retinylidene-phosphatidylethanolamine (N-Ret-PE), the Schiff base adduct of retinal and phosphatidylethanolamine, from the lumen to the cytoplasmic leaflet of disc membranes. This ensures that all-trans-retinal and excess 11-cis-retinal are efficiently cleared from photoreceptor cells thereby preventing the accumulation of toxic retinoid compounds. Loss-of-function mutations in the gene encoding ABCA4 cause autosomal recessive Stargardt macular degeneration, also known as Stargardt disease (STGD1), and related autosomal recessive retinopathies characterized by impaired central vision and an accumulation of lipofuscin and bis-retinoid compounds. High resolution structures of ABCA4 in its substrate and nucleotide free state and containing bound N-Ret-PE or ATP have been determined by cryo-electron microscopy providing insight into the molecular architecture of ABCA4 and mechanisms underlying substrate recognition and conformational changes induced by ATP binding. The expression and functional characterization of a large number of disease-causing missense ABCA4 variants have been determined. These studies have shed light into the molecular mechanisms underlying Stargardt disease and a classification that reliably predicts the effect of a specific missense mutation on the severity of the disease. They also provide a framework for developing rational therapeutic treatments for ABCA4-associated diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ABC transporters; ABCA4 disease variants; ABCA4 structure and function; Lipid transport; Stargardt disease; Visual cycle

Mesh:

Substances:

Year:  2021        PMID: 34954332     DOI: 10.1016/j.preteyeres.2021.101036

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   19.704


  4 in total

1.  Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a G protein-coupled receptor.

Authors:  Giulia Morra; Asghar M Razavi; Anant K Menon; George Khelashvili
Journal:  Structure       Date:  2022-06-03       Impact factor: 5.871

2.  Is There an Optimal Combination of AREDS2 Antioxidants Zeaxanthin, Vitamin E and Vitamin C on Light-Induced Toxicity of Vitamin A Aldehyde to the Retina?

Authors:  Małgorzata B Różanowska; Barbara Czuba-Pełech; Bartosz Różanowski
Journal:  Antioxidants (Basel)       Date:  2022-06-09

3.  Effective gene therapy of Stargardt disease with PEG-ECO/pGRK1-ABCA4-S/MAR nanoparticles.

Authors:  Da Sun; Wenyu Sun; Song-Qi Gao; Jonathan Lehrer; Amirreza Naderi; Cheng Wei; Sangjoon Lee; Andrew L Schilb; Josef Scheidt; Ryan C Hall; Elias I Traboulsi; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-24       Impact factor: 10.183

Review 4.  Polymeric biomaterials in the treatment of posterior segment diseases.

Authors:  Ivan Seah; Charles Ong; Zengping Liu; Xinyi Su
Journal:  Front Med (Lausanne)       Date:  2022-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.